Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Agrippal S1 influenza vaccine in Vietnamese volunteers
2014-005128-91Phase 2
- Sponsor
- Novartis
- Start
- Nov 2014
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of influenza vaccine, inactivated, surface antigen in influenza, sponsored by Novartis.
02
Drugs
influenza vaccine, inactivated, surface antigen
03
Conditions
influenza
Beyond the preview
Go deeper on 2014-005128-91.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005128-91.